Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "disorder"

620 News Found

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof


Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs
Medical Device | May 04, 2026

Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology


FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
News | May 02, 2026

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay


ARTEMIS study shows significant gains in adolescent mental health across urban slums in India
Healthcare | May 01, 2026

ARTEMIS study shows significant gains in adolescent mental health across urban slums in India

The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada


Monitra Health raises fresh funding  to scale upBeat® cardiac monitoring platform globally
Medical Device | April 30, 2026

Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans


Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis
Healthcare | April 29, 2026

Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis

The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder


Exciva initiates Phase 2/3 SERENADA trial for Alzheimer’s agitation therapy
Clinical Trials | April 29, 2026

Exciva initiates Phase 2/3 SERENADA trial for Alzheimer’s agitation therapy

The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation


Stryker launches Trident II Hip System in India
Medical Device | April 28, 2026

Stryker launches Trident II Hip System in India

New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty


LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
Hospitals | April 27, 2026

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders


Maarga Mind Care launches integrative day care program to bridge mental health recovery gap
Healthcare | April 27, 2026

Maarga Mind Care launches integrative day care program to bridge mental health recovery gap

New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery